News KYORIN Pharmaceutical Co., Ltd.

Equities

Market Closed - Japan Exchange Other stock markets 11:30:00 31/05/2024 am IST			5-day change	1st Jan Change
1,715 ^JPY	-0.06%		+0.76%	-3.65%

2023	ATyr Pharma to Obtain $10 Million in Milestone Payment After Partner Starts Dosing Patients in Lung Disease Study in Japan	MT
2021	KYORIN Holdings, Inc.(TSE:4569) dropped from S&P Japan 500	CI

KYORIN Pharmaceutical : Supplementary Information (May 11, 2024)	13/05	PU
Final dividend	28/03	FA
KYORIN Pharmaceutical : Integrated Report 2023 Batch download (Single Page) [ 10.6MB	29/23/29	PU
Ex-dividend day for interim dividend	28/23/28	FA
KYORIN Pharmaceutical : Summary of Consolidated Financial Results (August 2, 2023) [ 202 KB	02/23/02	PU
KYORIN Pharmaceutical : Supplementary Information (August 2, 2023) [ 530 KB	02/23/02	PU
Ex-dividend day for final dividend	30/23/30	FA
ATyr Pharma Announces Achievement of Development Milestone by Partner Kyorin Pharmaceutical, Co., Ltd	07/23/07	AQ
ATyr Pharma to Obtain $10 Million in Milestone Payment After Partner Starts Dosing Patients in Lung Disease Study in Japan	06/23/06	MT
KYORIN : 2Q FY2022 presentation for financial results	10/22/10	PU
Ex-dividend day for interim dividend	29/22/29	FA
Ex-dividend day for final dividend	30/22/30	FA
KYORIN Holdings, Inc.(TSE:4569) dropped from S&P Japan 500	20/21/20	CI
Ex-dividend day for interim dividend	29/21/29	FA
KYORIN : FY2020 presentation for financial results	12/21/12	PU
Otonomy : Reports First Quarter 2021 Financial Results and Provides Corporate Update	12/21/12	AQ
Ex-dividend day for final dividend	30/21/30	FA
Otonomy : Reports Third Quarter 2020 Financial Results and Provides Corporate Update	05/20/05	AQ
Ex-dividend day for interim dividend	29/20/29	FA
ATYR PHARMA : ANNOUNCES PARTNER KYORIN PHARMACEUTICAL CO., LTD. DOSES FIRST SUBJECTS IN PHASE 1 TRIAL OF ATYR1923 IN JAPAN	16/20/16	AQ

No results for this search